Financials
- Market Capitalization 427.19 M
- Employee 22
- Founded 2017
- CEO N/A
- Website www.q32bio.com
- Headquarter Delaware, United States
- FIGI BBG00CTTJWQ9
- Industry Fabricants de Médicaments — Généralités
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
4.08
ratio cours/chiffre d'affaires
120.41
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2741 | CBIO Crescent Biopharma, Inc. - Common Stock | 17.96 USD | +8.19% | +4.06% | +21.19% | +23.95% | 667.11 M USD | ||
| 2831 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.48 USD | +0.19% | -15.42% | +11.73% | -38.53% | 567.65 M USD | ||
| 3144 | UPB Upstream Bio, Inc. - Common Stock | 6.68 USD | +0.91% | -3.88% | +5.86% | -59.90% | 365.87 M USD | ||
| 3317 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.00 USD | +0.86% | -0.14% | -1.96% | -10.03% | 295.72 M USD |